NYSE:ABT

Abbott Laboratories Stock Insider Trading

Healthcare > Medical - Devices

Buy ABT

*Your capital is at risk

$87.02

+0.0600 (+0.0690%)

At Close: Jun 03, 2026

Abbott Laboratories Stock Insider Power

Based on the 100 latest insides trades, we have calculated the insider power to be positive at 84.82. In total, the insiders bought 1.73M and sold 90.18K ABT shares in the last 100 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.

Insider Power (Last 100 transactions)	84.82
● Buy	1.73M shares
● Sell	90.18K shares
75% Buy Activity Moderate Negative Correlation
Buy Signal Medium Confidence Feb 24, 2026 Analysis Breakdown: Strongly supported by a very high Insider Power Score of 84.82. Confidence increased due to high data reliability score of 100.

Historical Insider Trades

Date	Type	Person	Role	Amount
Apr 28, 2026 Buy	Common shares without par value I-Discretionary	Moreland Mary K Executive Vice President	CEO / President	5 314 Value: $501.7K
Apr 27, 2026 Buy	Common shares without par value P-Purchase	Starks Daniel J Director	Director	10 000 Value: $926.5K
Apr 24, 2026 Buy	Common shares without par value A-Award	Mcdew Darren W Director	Director	2 286 Value: $208.4K
Apr 24, 2026 Buy	Option (right to buy) A-Award	Mckinstry Nancy Director	Director	2 305 Value: $211.7K
Apr 24, 2026 Buy	Common shares without par value A-Award	Mckinstry Nancy Director	Director	2 286 Value: $208.4K
Apr 24, 2026 Buy	Option (right to buy) A-Award	O'grady Michael Director	Director	5 929 Value: $544.6K
Apr 24, 2026 Buy	Common shares without par value A-Award	O'grady Michael Director	Director	2 286 Value: $208.4K
Apr 24, 2026 Buy	Common shares without par value A-Award	Roman Michael F Director	Director	2 286 Value: $208.4K
Apr 24, 2026 Buy	Option (right to buy) A-Award	Starks Daniel J Director	Director	7 105 Value: $652.7K
Apr 24, 2026 Buy	Common shares without par value A-Award	Starks Daniel J Director	Director	2 286 Value: $208.4K
Apr 24, 2026 Buy	Common shares without par value A-Award	Stratton John G Director	Director	2 286 Value: $208.4K
Apr 24, 2026 Buy	Common shares without par value	Conroy Kevin T Director	Director	0 Value: $0
Apr 24, 2026 Buy	Common shares without par value A-Award	Conroy Kevin T Director	Director	2 286 Value: $208.4K
Apr 24, 2026 Buy	Common shares without par value A-Award	Kumbier Michelle Director	Director	2 286 Value: $208.4K
Apr 24, 2026 Buy	Common shares without par value A-Award	Gonzalez Patricia Paola Director	Director	2 286 Value: $208.4K
Apr 24, 2026 Buy	Common shares without par value A-Award	Blount Sally E. Director	Director	2 286 Value: $208.4K
Apr 24, 2026 Buy	Common shares without par value A-Award	Babineaux-fontenot Claire Director	Director	2 286 Value: $208.4K
Apr 24, 2026 Buy	Common shares without par value A-Award	Ahuja Nita Director	Director	2 286 Value: $208.4K
Apr 23, 2026 Buy	Common shares without par value P-Purchase	Boudreau Philip P EVP And CFO	C-Suite Officer	2 200 Value: $201.3K
Apr 23, 2026 Buy	Common shares without par value I-Discretionary	Boudreau Philip P EVP And CFO	C-Suite Officer	8 909 Value: $820.0K
Mar 31, 2026 Buy	Stock Equivalent Units A-Award	Ahuja Nita Director	Director	102 Value: $10.5K
Mar 31, 2026 Buy	Stock Equivalent Units A-Award	Alpern Robert J Director	Director	76 Value: $8K
Mar 31, 2026 Buy	Stock Equivalent Units A-Award	Gonzalez Patricia Paola Director	Director	321 Value: $32.9K
Mar 31, 2026 Buy	Stock Equivalent Units A-Award	Roman Michael F Director	Director	367 Value: $37.7K
Mar 31, 2026 Buy	Stock Equivalent Units A-Award	Stratton John G Director	Director	382 Value: $39.2K

About Insider Power

Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.

It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%^* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.

While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.

* October 6th, 2025 - Tested on 5562 stocks

ABOUT ABBOTT LABORATORIES

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepa...

Read Full Profile Here